Once-daily, steroid-free prescription topical treatment
for eczema in patients down to 2 years of age.
*Eligibility required. This offer is invalid for patients whose prescription claims are eligible to be reimbursed, in whole or in part, by any governmental program.
VTAMA cream is a once-daily, steroid-free prescription topical treatment for eczema in patients down to 2 years of age.
In clinical studies, up to 46% of patients using VTAMA cream achieved clear or almost clear skin compared to 18% of patients using cream with no active ingredient in 8 weeks†‡
Itch relief as early as Day 2 was reported in the pivotal studies by some patients
VTAMA cream is well tolerated on affected sensitive skin areas§, and safe enough to treat adults and children down to 2 years of age
The most common adverse reactions (incidence ≥1%) in patients with atopic dermatitis treated with VTAMA cream were upper respiratory tract infection, red raised bumps around the hair pores (folliculitis), lower respiratory tract infection, headache, asthma, vomiting, ear infection, pain in extremity, and stomach-area (abdominal) pain.
Ask your doctor if VTAMA cream
is right for you.
See the skin-clearing results from real patients with eczema who used once-daily, steroid-free VTAMA cream in clinical studies.
Ask your doctor if VTAMA cream is right for you.
VTAMA cream is a once-daily, steroid-free prescription topical treatment approved by the FDA for adults and children as young as 2 years of age with eczema (atopic dermatitis).
VTAMA cream is for use on affected skin (topical use) only. VTAMA cream can be used on affected sensitive skin areas, like your face and neck, armpits, chest/breasts, groin, and genitals. Do not use VTAMA cream in your eyes, mouth, or vagina.
Use VTAMA cream exactly as your healthcare provider tells you to use it.
Apply a thin layer of VTAMA cream only to affected areas one (1) time a day and rub it in until it absorbs. Avoid applying VTAMA cream to unaffected areas of your skin.
Wash your hands after applying VTAMA cream unless you are using it to treat eczema on your hands.
If someone else applies VTAMA cream for you, they should wash their hands after application.
Talk with your healthcare provider if you have questions about how to use VTAMA cream with moisturizers or cosmetic products.
The most common adverse reactions (incidence ≥1%) in patients with atopic dermatitis treated with VTAMA cream were upper respiratory tract infection, red raised bumps around the hair pores (folliculitis), lower respiratory tract infection, headache, asthma, vomiting, ear infection, pain in extremity, and stomach-area (abdominal) pain.
Don't worry! Apply as soon as you remember if it's still close to when you usually use it. If it's almost time for the next application, wait until then. Do not double the dose or use more than once daily. Continue treatment the next day like usual and use VTAMA cream as your healthcare provider instructed.
If you are having trouble keeping track of when to apply your VTAMA cream, consider setting a reminder to help.
Yes. VTAMA cream is a prescription medication. Talk to your healthcare provider about whether VTAMA cream is right for you. Learn more about getting started with VTAMA cream.
MyVTAMA is the patient support program from Dermavant, an Organon company. It was created to give you support and assistance along your eczema treatment journey.
Dermavant is committed to making VTAMA cream accessible and affordable to commercially insured patients with eczema. With the MyVTAMA Savings Card, commercially insured patients may pay as little as $0 and no more than $35.*
If you have any questions regarding your eligibility or benefits, call 347-532-5250 (9:00 AM - 7:00 PM ET).
*Eligibility required. This offer is invalid for patients whose prescription claims are eligible to be reimbursed, in whole or in part, by any governmental program.
VTAMA cream should be stored at room temperature, between 68 °F to 77 °F (20 °C to 25 °C).
It should not be frozen or exposed to excessive heat. Keep VTAMA cream and all medicines out of the reach of children.
Indications: VTAMA® (tapinarof) cream, 1% is an aryl hydrocarbon receptor agonist indicated for:
Adverse Events: In plaque psoriasis, the most common adverse reactions (incidence ≥1%) were: red raised bumps around the hair pores (folliculitis), pain or swelling in the nose and throat (nasopharyngitis), skin rash or irritation, including itching and redness, peeling, burning, or stinging (contact dermatitis), headache, itching (pruritus), and flu (influenza).
Adverse Events: In atopic dermatitis, the most common adverse reactions (incidence ≥1%) were: upper respiratory tract infection, red raised bumps around the hair pores (folliculitis), lower respiratory tract infection, headache, asthma, vomiting, ear infection, pain in extremity, and stomach-area (abdominal) pain.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
